Fred Alger Management »

Summit Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $105k 4.8k 21.90

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Inc Class A Common (META)
Broadcom Common (AVGO)
Natera Common (NTRA)
Applovin Corp Class A Common (APP)
Gfl Environmental Common (GFL)
Alphabet Inc Cl C Common (GOOG)
Taiwan Semiconductor Common (TSM)
Vertiv Holdings Common (VRT)
Visa Inc Class A Shares Common (V)
Netflix Common (NFLX)
S&p Global Common (SPGI)

View all positions for Fred Alger Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Darwin Global Management
Balyasny Asset Management
Northern Trust

View all funds holding Summit Therapeutics